Company news
Mesa Laboratories, Inc. (NASDAQ:MLAB) news
Every Mesa Laboratories, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Mesa Laboratories : Non-GAAP Reconciliation
August 10, 2026
Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
August 3, 2026
Mesa Laboratories : Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K)
June 3, 2026
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
May 27, 2026
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
May 5, 2026
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
March 9, 2026
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
February 18, 2026
Mesa Labs Announces Third Quarter Results
February 3, 2026
MESA LABS DECLARES QUARTERLY DIVIDEND
January 7, 2026
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
December 18, 2025
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
December 3, 2025
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences
November 12, 2025
Mesa Labs Announces Second Quarter Results
November 6, 2025
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
October 3, 2025
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
August 18, 2025
Mesa Labs Announces First Quarter Results
August 5, 2025
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
July 2, 2025
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
May 28, 2025
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
June 5, 2024
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
May 31, 2024
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
May 22, 2024
MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
April 8, 2024
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
April 1, 2024
Mesa Labs Releases Second Annual Responsible Business Program Brochure
March 15, 2024
Mesa Laboratories Appoints Mark Capone to its Board of Directors
January 8, 2024
Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
January 3, 2024
Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
December 14, 2023
Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform
October 16, 2023
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023
September 13, 2023
Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions
August 24, 2023
Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023
June 21, 2023
Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results
May 25, 2023
Mesa Laboratories, Inc. Reports Immaterial Financial Exposure to Silicon Valley Bank Closure
March 13, 2023
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023
March 9, 2023
Mesa Labs Releases Environmental, Social, and Governance Program Brochure
February 13, 2023
Mesa Labs Declares Quarterly Dividend
January 3, 2023
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023
December 16, 2022
Mesa Labs Acquires Belyntic’s Peptide Purification Business
November 17, 2022
Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director
November 4, 2022
Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
June 27, 2022
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
May 31, 2022
Mesa Labs Closes Acquisition of Agena Bioscience
October 20, 2021
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
September 14, 2021
Mesa Labs Reports Third Quarter Results for FY21
February 3, 2021
Mesa Labs Reports Second Quarter Results for FY21
November 5, 2020
Mesa Labs Reports First Quarter Results
August 6, 2020
Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering
June 16, 2020
Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
June 9, 2020
Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock
June 8, 2020
Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors
May 15, 2020